ZIOP-PGEN Fundamental & Technical Discussion Board - Bio2050 - ZIOP-PGEN Fundamental & Technical Discussion Board - InvestorVillage
ZIOP-PGEN Fundamental & Technical Discussion Board
This is a semi-private group. You are free to browse messages, but you must be a member of this group to post messages. Join This Group

Group: ZIOP-PGEN Fundamental & Technical Discussion Board   /  Message Board  /  Read Message

 
 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  21290 of 22279  at  11/27/2020 11:10:18 AM  by

Biotech2050


 In response to msg 21288 by  pharmionphil
view thread

Re: Bio2050

 Good. 
 
When the investigators see evidence of response within months the next step would be to increase number of participants to have meaningful data (N must be 50). Then they report the meaningful data. 
 
This is the path University of Washington took with PRGN-3005. It still boggles my mind that in the peak of covid initial scare in mid March they opted to increase participants from 41 to 71 and there were patients willing to participate (and not left to die). Why did they increase? Why did University of Washington launch a video? Why participate?
 
Now here is where I agree with you and normally JBWIN always responds to me with a post captioned "Reality check".
 
If, big caps IF,  either ZIOP or PGEN can show that their platform can cure metastatic nearly dead patients could they apply for FDA approval immediatley forgoing a phase 3 trial?
 
If not the 5 years is needed. I side with you on this but reality could be otherwise. 
 


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 4     Views: 0
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board








Financial Market Data provided by
.
Loading...